Technology | 2022.02.07
Bladder Cancer technology: New improved Blue Light Cystoscopy system receives FDA approval for use in NMIBC in the U.S.
OSLO, Norway, Feb. 7, 2022 /PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces U.S. Food and Drug Administration (FDA) approval of a new and improved Blue Light system to be used with Photocure\'s Cysview® product in Blue Light Cystoscopy (BLC®) procedures for the...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nmibc-in-the-us-301476307.html
